Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Asset Writedowns and Impairment (2020 - 2025)

Sight Sciences has reported Asset Writedowns and Impairment over the past 6 years, most recently at $101000.0 for Q4 2025.

  • Quarterly results put Asset Writedowns and Impairment at $101000.0 for Q4 2025, up 10200.0% from a year ago — trailing twelve months through Dec 2025 was $129000.0 (up 221.7% YoY), and the annual figure for FY2025 was $129000.0, up 221.7%.
  • Asset Writedowns and Impairment for Q4 2025 was $101000.0 at Sight Sciences, up from -$33000.0 in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for SGHT hit a ceiling of $376000.0 in Q3 2023 and a floor of -$250000.0 in Q1 2023.
  • Median Asset Writedowns and Impairment over the past 5 years was $30500.0 (2025), compared with a mean of $63950.0.
  • Biggest five-year swings in Asset Writedowns and Impairment: plummeted 3225.0% in 2023 and later surged 10200.0% in 2025.
  • Sight Sciences' Asset Writedowns and Impairment stood at $287000.0 in 2021, then fell by 3.14% to $278000.0 in 2022, then tumbled by 99.28% to $2000.0 in 2023, then plummeted by 150.0% to -$1000.0 in 2024, then surged by 10200.0% to $101000.0 in 2025.
  • The last three reported values for Asset Writedowns and Impairment were $101000.0 (Q4 2025), -$33000.0 (Q3 2025), and $26000.0 (Q2 2025) per Business Quant data.